Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy. Banerjee A, Li D, Guo Y, Mahgoub B, et al. J Immunol 2021;207:333-343.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Banerjee A, Li D, Guo Y, Mahgoub B, et al. Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy. J Immunol 2021;207:333-343.
PMID: 34155069